English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Clinical Trials
노보텍, 프리-ASCO중국 서밋 후원: 초기 단계 종양학 임상에 기반해 진행 여부 결정
May 12, 2022 21:00 HKT
Elevating Australia's Scientific Acumen: Large Molecule Facility Doubles Size of Australia's Top Bioanalytical Laboratory
May 12, 2022 15:00 HKT
Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials
May 12, 2022 06:00 HKT
Novotech 赞助 ASCO 中国峰会前夕:基于早期肿瘤学试验的 Go/No Go 决策
May 12, 2022 06:00 HKT
Novotech Acquires US CRO NCGS, Expands Global Expertise
May 05, 2022 09:00 HKT
아방스 클리니컬, 인포마파마인텔리전스 어워드 2022에서 아태지역 최고CRO상 최종 후보로 선정
Apr 20, 2022 16:00 HKT
Avance Clinical進入Informa Pharma Intelligence 2022年亞太地區最佳CRO最終候選名單
Apr 19, 2022 10:02 HKT
Avance Clinical进入Informa Pharma Intelligence 2022年亚太地区最佳CRO最终候选名单
Apr 19, 2022 10:01 HKT
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 - Best Contract Research Organization in APAC
Apr 19, 2022 10:00 HKT
아방스 클리니컬, 멜버른에 신규 사업소 개설 발표
Apr 02, 2022 06:00 HKT
Avance Clinical Announces New Office Opening in Melbourne
Mar 31, 2022 15:00 HKT
Avance Clinical墨尔本办公室正式启动
Mar 31, 2022 15:00 HKT
Avance Clinical墨爾本辦公室正式啟動
Mar 31, 2022 15:00 HKT
Avance Clinical Announces New Office Opening in Sydney
Mar 02, 2022 15:00 HKT
Avance Clinical悉尼办公室正式启动
Mar 02, 2022 15:00 HKT
Avance Clinical悉尼辦公室正式啟動
Mar 02, 2022 15:00 HKT
Therapeutic Goods Administration of Australia Authorizes Moderna's Covid-19 Vaccine in Children (6-11 Years)
Feb 17, 2022 10:45 HKT
Moderna Announces Plan to Expand Footprint in Asia with Four Additional Subsidiaries
Feb 16, 2022 07:00 HKT
Novotech Recognized as Top 10 CRO in CenterWatch Global Site Relationship Benchmarking Report
Feb 09, 2022 15:00 HKT
Avance Clinical在2022年生物技術展上宣佈為美國擴張進行重大私募股權投資
Jan 19, 2022 07:00 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: